UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
April 17, 2026
_______________________
AEHR TEST SYSTEMS |
(Exact name of registrant as specified in its charter) |
California | 000-22893 | 94-2424084 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||
400 KATO TERRACE FREMONT, CA 94539 | ||||
(Address of principal executive offices, including zip code) | ||||
510-623-9400 | ||||
(Registrant’s telephone number, including area code) | ||||
N/A | ||||
(Former name or former address, if changed since last report) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value$0.01 per share | AEHR | The NASDAQ Capital Market |
Item 8.01. Other Events.
On April 17, 2026, Aehr Test Systems, a California corporation (the “Company”), fully utilized its previously announced at-the-market equity offering program and completed sales of shares of its common stock having aggregate gross proceeds of approximately $60.0 million. The shares were offered and sold pursuant to the Company’s effective registration statement on Form S-3 (File No. 333-282661), which registered up to $100.0 million of securities, and the prospectus supplement dated April 8, 2026.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
| Description |
|
|
|
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AEHR TEST SYSTEMS | |||
| Date: April 18, 2026 | By: | /s/ Chris P. Siu | |
|
| Chris P. Siu Executive Vice President of Finance and Chief Financial Officer | |
3 |